WO2012019203A3 - Therapeutic agent for intranasal administration and method of making and using same - Google Patents

Therapeutic agent for intranasal administration and method of making and using same Download PDF

Info

Publication number
WO2012019203A3
WO2012019203A3 PCT/US2011/051976 US2011051976W WO2012019203A3 WO 2012019203 A3 WO2012019203 A3 WO 2012019203A3 US 2011051976 W US2011051976 W US 2011051976W WO 2012019203 A3 WO2012019203 A3 WO 2012019203A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic agent
intranasal administration
making
same
nordihydrocapsaicin
Prior art date
Application number
PCT/US2011/051976
Other languages
French (fr)
Other versions
WO2012019203A2 (en
Inventor
Wayne Jeffrey Perry
Lynne M. Millheiser
Original Assignee
Dynova Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/849,088 external-priority patent/US20100322961A1/en
Application filed by Dynova Laboratories, Inc. filed Critical Dynova Laboratories, Inc.
Publication of WO2012019203A2 publication Critical patent/WO2012019203A2/en
Publication of WO2012019203A3 publication Critical patent/WO2012019203A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a composition suitable for intranasal administration comprising capsaicin, dihydrocapsaicin, and nordihydrocapsaicin in the form of capsicum used as a therapeutic agent.
PCT/US2011/051976 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same WO2012019203A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/849,088 2010-08-03
US12/849,088 US20100322961A1 (en) 2007-03-30 2010-08-03 Intranasal Drug Delivery System
US40539010P 2010-10-21 2010-10-21
US61/405,390 2010-10-21

Publications (2)

Publication Number Publication Date
WO2012019203A2 WO2012019203A2 (en) 2012-02-09
WO2012019203A3 true WO2012019203A3 (en) 2012-03-29

Family

ID=45560117

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2011/051981 WO2012019204A2 (en) 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same
PCT/US2011/051976 WO2012019203A2 (en) 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2011/051981 WO2012019204A2 (en) 2010-08-03 2011-09-16 Therapeutic agent for intranasal administration and method of making and using same

Country Status (1)

Country Link
WO (2) WO2012019204A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171316A1 (en) * 2012-03-14 2012-07-05 Forces Of Nature, Inc. Method for manufacturing homeopathic mixtures
US20120183624A1 (en) * 2012-03-23 2012-07-19 Forces Of Nature, Inc. Method for manufacturing homeopathic personal care products
CA2880035A1 (en) * 2012-08-24 2014-02-27 Anjan Chatterjee Composition for the treatment of migraine headaches
US20140120077A1 (en) 2012-10-28 2014-05-01 Revance Therapeutics, Inc. Compositions and Methods for Safe Treatment of Rhinitis
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151792A1 (en) * 2001-06-20 2004-08-05 Tripp Matthew L. Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
US20090312724A1 (en) * 2007-06-28 2009-12-17 Cydex Pharmaceuticals, Inc. Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151792A1 (en) * 2001-06-20 2004-08-05 Tripp Matthew L. Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20090312724A1 (en) * 2007-06-28 2009-12-17 Cydex Pharmaceuticals, Inc. Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALCON: "Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms", 15 April 2008 (2008-04-15), Retrieved from the Internet <URL:http://invest.alconinc.com/phoenix.zhtml?c=130946&p=irol-newsArticlePrint&ID=1129960&highlight=> [retrieved on 20120111] *

Also Published As

Publication number Publication date
WO2012019204A2 (en) 2012-02-09
WO2012019204A3 (en) 2012-03-22
WO2012019203A2 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
IL269322B (en) Methylphenidate-prodrugs, processes of making and using the same
HK1220631A1 (en) Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
IL233154A (en) Compounds, pharmaceutical compositions comprising the same and uses thereof
IL227963A0 (en) Cytotxic benzodiazepine derivatives, compositions comprising the same and uses thereof
WO2011130615A3 (en) Preparation of lacosamide
EP2670733A4 (en) Hdac inhibitors and therapeutic methods using the same
WO2011150201A3 (en) Azolyl amide compounds and methods of use thereof
WO2012019204A3 (en) Therapeutic agent for intranasal administration and method of making and using same
EP2361907A4 (en) The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
HK1200392A1 (en) Acetaminophen conjugates, compositions and methods of use thereof
ZA201209674B (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
IL227816A0 (en) Peptide library, constructs comprising the same and methods of use of the same
HK1207563A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2011088272A9 (en) Selective ampd2 inhibitors and methods for using the same
WO2010059967A3 (en) Amide inhibitors of renin
IL230655A0 (en) N-hetero-ring-substituted amide derivatives, compositions comprising the same and uses thereof
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2012139074A3 (en) Migrastatins and uses thereof
WO2012119045A3 (en) Compositions and uses thereof to ameliorate pain
HK1204940A1 (en) Pharmaceutical composition comprising (1r,4r)-6-fluoro-n,n-dimethyl- 4-phenyl-4,9-dihydro-3h-spiro[cyclohexane-1,1- pyrano[3,4,b]indol]-4-amine and paracetamol or propacetamol (1r4r)-6--nn--4--49--3h-[- 11-[34b]]-4-
EP2629767A4 (en) Amide derivatives of benzene-sulfonanilide, pharmaceutical composition thereof and method for cancer treatment using the same
HUP1000690A2 (en) Cosmetic product comprising capsaicin and essential oil as active agents, method for the production and use thereof
EP2781521A4 (en) Novel spiroindoline compound, and medicinal agent comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11815427

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 09/04/2013)

122 Ep: pct application non-entry in european phase

Ref document number: 11815427

Country of ref document: EP

Kind code of ref document: A2